Showing 13–24 of 30 results

Show sidebar
Show 9 12 18 24
Compare

PNC-27 30mg

, ,
£79.00

PNC-27 is a membrane-active peptide studied in oncology research for its selective binding to HDM-2 in cancer cells. It induces

Add to wishlist
Add to cart
Quick view
Compare

Retatrutide 10mg

£39.00

Retatrutide is a powerful triple agonist peptide that targets GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—making it the most comprehensive metabolic peptide

Add to wishlist
Add to cart
Quick view
Compare

Retatrutide 20mg

,
£54.00

Retatrutide is a powerful triple agonist peptide that targets GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—making it the most comprehensive metabolic peptide

Add to wishlist
Add to cart
Quick view
Compare

Retatrutide 30mg

,
£74.00

Retatrutide is a powerful triple agonist peptide that targets GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—making it the most comprehensive metabolic peptide

Add to wishlist
Add to cart
Quick view
Compare

Retatrutide 40mg

,
£99.00

Retatrutide is a powerful triple agonist peptide that targets GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—making it the most comprehensive metabolic peptide

Add to wishlist
Add to cart
Quick view
Compare

Retatrutide 50mg

,
£134.00

Retatrutide is a powerful triple agonist peptide that targets GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—making it the most comprehensive metabolic peptide

Add to wishlist
Add to cart
Quick view
Compare

Retatrutide 60mg

,
£159.00

Retatrutide is a powerful triple agonist peptide that targets GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—making it the most comprehensive metabolic peptide

Add to wishlist
Add to cart
Quick view
Compare

Semaglutide 10mg

£49.00

Originally developed as a medication to treat Type-2 Diabetes, Semaglutide has been adopted as an effective tool to combat obesity in

Add to wishlist
Add to cart
Quick view
Compare

Semaglutide 15mg

,
£69.00

Originally developed as a medication to treat Type-2 Diabetes, Semaglutide has been adopted as an effective tool to combat obesity in

Add to wishlist
Add to cart
Quick view
Compare

Semaglutide 5mg

,
£29.00

Originally developed as a medication to treat Type-2 Diabetes, Semaglutide has been adopted as an effective tool to combat obesity in

Add to wishlist
Add to cart
Quick view
Compare

SLU-PP-332 5mg

£24.95

SL-UP-332 is a synthetic research compound known as an “exercise mimetic” that shows promise in animal studies for treating metabolic diseases,

Add to wishlist
Add to cart
Quick view
Compare

Survodutide 10mg

£49.00

Survodutide is a dual agonist of the GLP-1 and glucagon receptors, originally developed as a treatment for Type-2 Diabetes and obesity. Like other GLP-1

Add to wishlist
Add to cart
Quick view